跳至主要内容
临床试验/NCT04763161
NCT04763161尚未招募不适用

Immuno-inflammation in the Acute Phase of an Ischaemic Cerebral Accident Managed by Decompressive Hemicraniectomy: a Case-control Study

Fondation Ophtalmologique Adolphe de Rothschild0 个研究点目标入组 90 人开始时间: 2026年8月15日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
90
主要终点
neutrophil polynuclear cells levels

研究概览

简要总结

The objective of the NEUTROSURGERY study is to describe the local and locoregional immuno-inflammatory activity in patients suffering from malignant sylvian ischaemic cerebral accident and treated with decompressive hemicraniectomy compared to a control population of patients to be operated on in neurosurgery for another neurosurgical pathology.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Collegial indication given by a neurologist, a neuroreanimator and a neurosurgeon for HD in the context of a malignant sylvian AIC.
  • Inclusion Criteria Control:
  • - For neurosurgical operations in which cranial, meningeal, vascular (branch of the middle meningeal artery) or cerebral bone tissue is not preserved during the surgical approach.
  • Non-inclusion Criteria Patients:
  • HD carried out in a context of acute cerebral haemorrhage
  • Pre-existing neurological disability: modified Rankin score > 2
  • Patient benefiting from a legal protection measure
  • Non-inclusion Criteria Controls:
  • Patient to be operated on for an acute vascular condition: meningeal haemorrhage, subdural or extradural haemorrhage, intra parenchymal haemorrhage.
  • Patient operated on for an osteomeningeal pathology present at the approach site.
  • Patient operated on for an infectious cranial or neuro-meningeal pathology.
  • Patient to be operated on as a result of an intracranial traumatic condition

排除标准

  • 未提供

结局指标

主要结局

neutrophil polynuclear cells levels

时间窗: Day 0

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

相似试验

Immuno-inflammation in the Acute Phase of an... | 临床试验